Fri, Jul 25, 2014, 9:04 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Roche Holding AG Message Board

  • pfizerpatentexpiration pfizerpatentexpiration Oct 20, 2011 8:52 PM Flag

    Pascal, congratulations acquiring Anadys, any update on Oxigene?

    I know you guys know best but Novartis could at any day now surprise you and offer to buy Zybrestat and their VDA patent portfolio.

    As we know, once Oxigene presents it will be too obvious that zybrestat is the blockbuster for destroying cancerous tumors, not to mention its other applications. Since Novartis and Astra know zybrestat's molecular structure is superior, hence the prolonged survival after 12 months now, what's to stop them from beating you to the table?

    So if Roche waits any longer they risk the stock soaring on the data as the market realizes zybrestat is the most efficacious of all the agents that were determined years ago.

    Just my thoughts.

    Again, great job acquiring Anadys; with Setrobuvir the Hep C market is now yours!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • they're considering Catalyst Pharmaceutical Partners for addressing the drug addiction market.
      The company's stock symbol is CPRX and trades around $1.00 per share. Dendreon Corp's former genius exec recently joined Catalyst too.

      Pascal knows where the blockbuster potential is.

36.905-0.335(-0.90%)Jul 25 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.